Why the study?
Elderly hip fracture patients are at risk of stress-related gastric mucosal damage and underrecognized upper gastrointestinal bleeding, but evidence on prophylactic proton pump inhibitor use in this population is limited.
Do proton pump inhibitors reduce upper gastrointestinal bleeding and 90-day mortality in elderly patients with hip fractures?
Do proton pump inhibitors reduce upper gastrointestinal bleeding and 90-day mortality in elderly patients with hip fractures?
Peri-operative prophylactic use of proton pump inhibitors in elderly hip fracture patients may significantly reduce upper gastrointestinal bleeding and 90-day mortality.
May support PPI prophylaxis in elderly hip fracture patients; leaves open confirmation by randomized trials.
Elderly hip fracture patients are at risk of stress-related gastric mucosal damage, and upper gastrointestinal bleeding is one of the underrecognized but devastating complications. Proton pump inhibitors (PPIs) offer effective prophylaxis against stress-related gastric mucosal damage. Systematic analysis of the literature revealed numerous articles on PPIs and hip fractures, but only three articles dedicated to the analysis of prophylactic use of PPIs in patients with a hip fracture. There is significant reduction in upper gastrointestinal bleeding following PPI prophylaxis and reduced 90-day mortality in elderly hip fracture patients on prophylaxis. PPIs are generally safe, cost-effective and based on available evidence. Their prophylactic use is justifiable in elderly patients with hip fractures. We suggest that PPIs be prescribed routinely peri-operatively in elderly hip fracture patients. Further level-one studies on the subject will allow for firmer recommendations. Cite this article: EFORT Open Rev 2021;6:686-691. DOI: 10.1302/2058-5241.6.200053
No takes yet. Share an insight, caveat, or question.
Chuene et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: